Alvotech (ALVOW) Receivables (2020 - 2025)
Alvotech (ALVOW) reported Receivables of $71.0 million for Q4 2025, down 55.81% on a YoY basis from $160.6 million in Q4 2024, and down 55.97% quarter-over-quarter from $161.2 million in Q3 2025.
Alvotech (ALVOW) Receivables (2020 - 2025) Analysis & Trends
Alvotech has reported Receivables for 6 years, with the latest figure at $71.0 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables fell 55.81% year-over-year to $71.0 million; the trailing twelve-month figure through Dec 2025 stood at $71.0 million (down 55.81% YoY), and the FY2025 full-year result was $71.0 million, down 55.81% from the prior year.
- Receivables for Q4 2025 stood at $71.0 million, down from $161.2 million in the prior quarter.
- The five-year high for Receivables was $168.5 million in Q1 2025, with the low at $6.8 million in Q2 2022.
- Historically, Receivables has averaged $74.7 million across 5 years, with a median of $56.6 million in 2024.
- Annual changes were most pronounced in 2021 — Receivables surged 3045.05% — and 2025, when it plunged 55.81%.
- Alvotech's Receivables stood at $30.5 million in 2021, then climbed by 13.15% to $34.5 million in 2022, then gained by 22.21% to $42.2 million in 2023, then surged by 280.74% to $160.6 million in 2024, then sank by 55.81% to $71.0 million in 2025.
- The last three Receivables figures came in at $71.0 million (Q4 2025), $161.2 million (Q3 2025), and $108.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 70.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 70.98 Mn |
| Sep 30, 2025 | 161.22 Mn |
| Jun 30, 2025 | 108.28 Mn |
| Mar 31, 2025 | 168.49 Mn |
| Dec 31, 2024 | 160.63 Mn |
| Sep 30, 2024 | 77.46 Mn |
| Jun 30, 2024 | 93.57 Mn |
| Mar 31, 2024 | 42.29 Mn |
| Dec 31, 2023 | 42.19 Mn |
| Jun 30, 2023 | 17.96 Mn |
| Mar 31, 2023 | 31.57 Mn |
| Dec 31, 2022 | 34.52 Mn |
| Jun 30, 2022 | 6.80 Mn |
| Dec 31, 2021 | 30.51 Mn |
| Dec 31, 2020 | 970,000.00 |